REGNvsVRTX
Regeneron Pharmaceuticals IncvsVertex Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Regeneron Pharmaceuticals Inc
$766.02
+3.34%
Vertex Pharmaceuticals Inc
$435.1
-4.37%
60-day price, rebased to 100
Round-by-round
Valuation upside
-22.60% vs -43.10% to DCF fair value
Balance-sheet strength
Altman Z 7.40 vs 12.39
Fundamental quality
Piotroski 5.00 vs 6.00 (of 9)
Growth + margins
Rule-of-40 27.20 vs 35.50
60-day momentum
+1.98% vs -7.41% price return
Market-cap liquidity
$79.2B vs $119.2B
Verdict
Across6categories,VRTXtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onREGNorVRTX
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.